Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease

Dementia Matters by Wisconsin Alzheimer‘s Disease Research Center

Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapies after decades of research and clinical trials. A recent review published by Cochrane, a global, independent, non...View more